National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 9) (PB 106 of 2015) (Cth)

PB 106 of 2015

National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 9)

National Health Act 1953

I, ADRIANA PLATONA, Assistant Secretary , Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.

Dated        26   October 2015

ADRIANA PLATONA

Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health

Part 1         Preliminary

1. Name of Determination

   (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2015 (No. 9).

   (2)   This Determination may also be cited as PB 106 of 2015.

2. Commencement

   This Determination commences on 1 November 2015.

3. Amendment of National Health (Listed drugs on F1 or F2) Determination 2010

   Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).

Schedule 1             Amendments

(Section 3)

[1]     Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate, vitamins, minerals and trace elements without phenylalanine and tyrosine and supplemented with docosahexanoic acid

Insert

Amino acid formula with fat, carbohydrate, vitamins, minerals, trace elements and medium chain triglycerides

[2]     Schedule 1, after item dealing with Lithium

Insert

Lurasidone

[3]     Schedule 1, after item dealing with Pomalidomide

Insert

Ponatinib